Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats

BACKGROUND: PPARγ agonists ameliorate insulin resistance and dyslipidemia in type 2 diabetic patients. Adiponectin possesses insulin sensitizing properties, and predicts insulin sensitivity of both glucose and lipid metabolism. In diet-induced insulin resistant rats and ZDF rats, the current studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Baichun, Brown, Kathleen K, Chen, Lihong, Carrick, Kevin M, Clifton, Lisa G, McNulty, Judi A, Winegar, Deborah A, Strum, Jay C, Stimpson, Stephen A, Pahel, Gregory L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526775/
https://www.ncbi.nlm.nih.gov/pubmed/15491498
http://dx.doi.org/10.1186/1471-2210-4-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526775/
https://www.ncbi.nlm.nih.gov/pubmed/15491498
http://dx.doi.org/10.1186/1471-2210-4-23

Ejemplares similares